2023 | Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial | Avihingsanon, Anchalee; Lu, Hongzhou; Leong, Chee Loon; CHIEN-CHING HUNG ; Koenig, Ellen; Kiertiburanakul, Sasisopin; Lee, Man-Po; Supparatpinyo, Khuanchai; Zhang, Fujie; Rahman, Sophia; D'Antoni, Michelle L; Wang, Hongyuan; Hindman, Jason T; Martin, Hal; Baeten, Jared M; Li, Taisheng | The lancet. HIV | 9 | 1 | |